As of November 2026 Latigo Biotherapeutics has a market cap of NZ$1.73 Billion. This makes Latigo Biotherapeutics the world's 6307th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 3rd, 2026 the market cap of Latigo Biotherapeutics was reported to be: